Legionella Testing Market: Industry Analysis and Forecast (2026–2032)

Market Overview

The global Legionella Testing Market plays an important role in public health protection by enabling the detection of Legionella bacteria in water systems and clinical samples. These bacteria can cause Legionnaires’ disease, a serious form of pneumonia, as well as Pontiac fever, a milder illness. Legionella can multiply in building water systems, cooling towers, hot tubs, and other water environments under favorable conditions. Regular testing helps identify contamination risks and supports appropriate prevention and control measures.

According to Maximize Market Research, the global Legionella Testing Market was valued at USD 371.73 million in 2025. Growing awareness of waterborne infections, increased attention to water quality, and rising demand for reliable diagnostic technologies are supporting market development. Hospitals, laboratories, water treatment companies, and building operators are increasingly adopting testing solutions to improve safety and manage contamination risks.

Download Free PDF Brochure@https://www.maximizemarketresearch.com/request-sample/228914/ 

Market Size and Growth

The Legionella Testing Market is projected to grow at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2032, reaching approximately USD 666.56 million by 2032. This growth reflects the increasing importance of disease prevention, environmental monitoring, and accurate microbial detection.

Healthcare facilities and commercial buildings require effective water management practices to reduce the risk of Legionella contamination. Growing urbanization and aging water infrastructure can create conditions in which bacteria develop in complex plumbing systems. Consequently, demand for routine environmental testing and clinical diagnostic solutions is increasing.

Technological advancements are also improving testing efficiency. Conventional culture methods remain important, while molecular techniques such as polymerase chain reaction (PCR) can provide faster detection. These developments are encouraging laboratories and testing providers to expand their capabilities and adopt more efficient diagnostic workflows.

Key Market Segmentation

The Legionella Testing Market is segmented by test type, sample type, technology, application, and end-user.

By Test Type: The market includes microbial culture, urine antigen testing, PCR, serology, and direct fluorescent antibody testing. Microbial culture held the leading position in 2025 because it allows laboratories to isolate and identify Legionella bacteria. It also provides useful information for further characterization and supports established testing procedures. PCR is emerging as a rapidly developing segment because it can detect bacterial genetic material and deliver results more quickly than conventional culture methods in appropriate settings.

By Sample Type: Major categories include water samples, biofilm samples, swab samples, respiratory samples, urine samples, and blood samples. Water testing is important for identifying environmental contamination, while respiratory and urine samples support clinical diagnosis.

By Technology: The market includes real-time PCR, multiplex PCR, loop-mediated isothermal amplification (LAMP), next-generation sequencing (NGS), and immunoassay-based testing.

By Application and End-User: Applications include water testing and in-vitro diagnostic (IVD) testing. Key end-users include hospitals and clinics, environmental testing providers, diagnostic laboratories, and water treatment industries.

Growth Drivers

The increasing risk of waterborne infections is a major factor driving the Legionella Testing Market. Legionnaires’ disease can cause severe respiratory illness, particularly among older adults and people with certain underlying health conditions. Greater awareness of infection risks is encouraging healthcare providers and building operators to strengthen monitoring and prevention programs.

Aging water infrastructure is another important growth driver. Water systems in hospitals, hotels, residential buildings, and industrial facilities may provide environments where Legionella can multiply. Regular testing helps identify potential problems and supports timely corrective action.

Stricter water safety practices and growing healthcare expenditure are also encouraging adoption. Hospitals and diagnostic laboratories require reliable methods to identify infections, while commercial facilities need environmental testing to support water management plans. Increased urbanization and construction of large buildings further contribute to demand.

Emerging Trends

Advances in molecular diagnostics are transforming Legionella testing. Real-time PCR and multiplex PCR technologies can detect bacterial genetic material and help laboratories process samples more efficiently. These methods are particularly useful when timely results are important for investigations and risk management.

Rapid testing technologies, including antigen tests and immunoassays, are also gaining attention. Point-of-care testing can support faster clinical decision-making, although the appropriate method depends on the sample, intended use, and clinical context.

Automation and digital data management represent additional trends. Automated laboratory workflows can reduce manual processing, while digital platforms help organize test results and monitor water quality over time. Companies are also investing in improved testing kits, simplified procedures, and partnerships between diagnostic laboratories and water treatment providers.

Regional Analysis

North America dominated the Legionella Testing Market in 2025, supported by established healthcare infrastructure, awareness of Legionnaires’ disease, and water safety management practices. The United States is a key market, where guidance from organizations such as the Centers for Disease Control and Prevention and industry standards helps inform Legionella risk management. Demand is supported by testing requirements and monitoring activities across healthcare, hospitality, and industrial facilities.

Europe is another significant market, accounting for approximately 30% of market share in 2025. Regulations and established water quality monitoring practices support demand for testing services. Countries including France, Germany, Italy, and Spain offer opportunities for diagnostic providers and environmental testing laboratories.

Asia Pacific is expected to be the fastest-growing region, with a reported CAGR of 8.7%. Urbanization, expanding healthcare infrastructure, and the development of complex building water systems in countries such as China and India are increasing demand for regular testing. South America and the Middle East and Africa also offer opportunities as water safety awareness and testing capabilities improve.

Competitive Landscape

The Legionella Testing Market is competitive, with diagnostic manufacturers, laboratory technology providers, and environmental testing companies focusing on product innovation, testing accuracy, and broader market access.

Key players identified by Maximize Market Research include Quidel Corporation, Abbott, Merck KGaA, IDEXX Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Pall Corporation, Becton, Dickinson and Company, Roche Diagnostics, Hologic, Inc., QIAGEN, and Eiken Chemical Co. Ltd.

Companies compete through improvements in culture media, diagnostic kits, molecular testing systems, and laboratory services. Strategic partnerships, acquisitions, distribution agreements, and research and development investments are important approaches for strengthening product portfolios and expanding geographical reach.

Download Free PDF Brochure@https://www.maximizemarketresearch.com/request-sample/228914/ 

Recent Developments

The market report highlights several developments involving testing services and diagnostic technology providers.

• February 2023: Eurofins Scientific acquired Bio-Rad Clinical Diagnostics, strengthening its diagnostic services portfolio and expanding its geographical reach.

• January 2023: Mérieux NutriSciences acquired Silliker Laboratories, enhancing its environmental testing capabilities, including Legionella analysis.

• 2023: Bio-Rad Laboratories partnered with Quidel Corporation to expand access to Quidel’s point-of-care Legionella antigen test through Bio-Rad’s distribution network.

• 2023: Hygiena partnered with RKI-CERT GmbH to support the standardization and validation of Legionella testing methods.

These developments illustrate the importance of collaboration, expanded distribution, and testing standardization in the market.

Future Outlook

The Legionella Testing Market is expected to grow steadily through 2032 as healthcare providers, building operators, and water treatment companies prioritize microbial monitoring and prevention. The projected market value of USD 666.56 million reflects opportunities in environmental testing, clinical diagnostics, and rapid detection technologies.

PCR-based testing, automation, and digital monitoring tools are likely to remain important areas of development. Emerging economies may provide additional growth opportunities as infrastructure investment and awareness of water safety increase.

However, the market may face challenges related to testing costs, laboratory capacity, technical expertise, and differences in regulatory requirements. Manufacturers that provide reliable, accurate, and accessible testing solutions will be better positioned to meet evolving customer needs.

For full access to the comprehensive strategic report, visit:https://www.maximizemarketresearch.com/market-report/legionella-testing-market/228914/ 

Conclusion

The global Legionella Testing Market is becoming increasingly important as organizations strengthen water safety measures and seek effective methods for detecting harmful bacteria. Valued at USD 371.73 million in 2025, the market is projected to reach USD 666.56 million by 2032 at a CAGR of 8.7%. Microbial culture remains the leading test type, while PCR and other rapid technologies offer opportunities for faster detection. With rising awareness of waterborne infections, improved diagnostic technologies, and greater emphasis on environmental monitoring, the market is expected to maintain steady growth.

About Maximize Market Research